Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials
Back
14 Apr 2024
9:54 a.m.
10:12 a.m.
Ogo
Egbuna
Speaker
United States
Vertex Pharmaceuticals Inc
Add to My Schedule